speb/financial-data huggingface dataset:
AOMR cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1883000.00
AOMR cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: -369000.00
AOMR cash_flow (annual, 2024-12-31) — Common Stock Payments: -19950000.00
AOMR cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
AOMR balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 3057000.00
AOMR balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
AOMR income_statement (annual, 2024-12-31) — Diluted Average Shares: 24396851.00
AOMR income_statement (annual, 2024-12-31) — Diluted EPS: 1.17
AOMR income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 28595000.00
AOMR cash_flow (annual, 2024-12-31) — End Cash Position: 42893000.00
AOMR cash_flow (annual, 2024-12-31) — Financing Cash Flow: 99317000.00
AOMR cash_flow (annual, 2024-12-31) — Free Cash Flow: -221468000.00
AOMR income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 4093000.00
AOMR balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -3475000.00
AOMR income_statement (annual, 2024-12-31) — General And Administrative Expense: 2041000.00
AOMR cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 1717000.00
AOMR balance_sheet (annual, 2024-12-31) — Income Tax Payable: 2785000.00
AOMR income_statement (annual, 2024-12-31) — Interest Expense: 73502000.00
AOMR income_statement (annual, 2024-12-31) — Interest Income: 110427000.00
AOMR cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 66310000.00
AOMR balance_sheet (annual, 2024-12-31) — Invested Capital: 2009778000.00
AOMR cash_flow (annual, 2024-12-31) — Investing Cash Flow: 120548000.00
AOMR balance_sheet (annual, 2024-12-31) — Investments And Advances: 326516000.00
AOMR cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1883000.00
AOMR cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: -369000.00
AOMR cash_flow (annual, 2024-12-31) — Issuance Of Debt: 48425000.00
AOMR cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: -317225000.00
AOMR balance_sheet (annual, 2024-12-31) — Long Term Debt: 1770811000.00
AOMR balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1770811000.00
AOMR cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 48425000.00
AOMR cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: -317225000.00
AOMR cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -331619000.00
AOMR balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 20680000.00
AOMR cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -18067000.00
AOMR cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -369000.00
AOMR balance_sheet (annual, 2024-12-31) — Net Debt: 1730049000.00
AOMR income_statement (annual, 2024-12-31) — Net Income: 28750000.00
AOMR income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 28595000.00
AOMR income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 28750000.00
AOMR income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 28750000.00
AOMR income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 28750000.00
AOMR cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 28750000.00
AOMR income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 28750000.00
AOMR income_statement (annual, 2024-12-31) — Net Interest Income: 36925000.00
AOMR cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 120515000.00
AOMR cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -283194000.00
AOMR cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -283194000.00
AOMR cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 574716000.00
AOMR cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 575729000.00
AOMR balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 238967000.00
AOMR income_statement (annual, 2024-12-31) — Normalized Income: 28750000.00
AOMR cash_flow (annual, 2024-12-31) — Operating Cash Flow: -221468000.00
AOMR cash_flow (annual, 2024-12-31) — Operating Gains Losses: 9228000.00
AOMR income_statement (annual, 2024-12-31) — Operating Revenue: 51458000.00
AOMR balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 23500175.00
AOMR balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -3475000.00
AOMR cash_flow (annual, 2024-12-31) — Other Non Cash Items: -256252000.00
AOMR income_statement (annual, 2024-12-31) — Other Non Interest Expense: 17406000.00
AOMR balance_sheet (annual, 2024-12-31) — Payables: 206379000.00
AOMR balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 209436000.00
AOMR income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 155000.00
AOMR income_statement (quarterly, 2024-12-31) — Preferred Stock Dividends: 40000.00
AOMR balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1095000.00
AOMR income_statement (annual, 2024-12-31) — Pretax Income: 32011000.00
AOMR cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1503222000.00
AOMR balance_sheet (annual, 2024-12-31) — Receivables: 8141000.00
AOMR cash_flow (annual, 2024-12-31) — Repayment Of Debt: -331619000.00
AOMR cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -19950000.00
AOMR cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
AOMR balance_sheet (annual, 2024-12-31) — Retained Earnings: -218849000.00
AOMR income_statement (annual, 2024-12-31) — Salaries And Wages: 2041000.00
AOMR cash_flow (annual, 2024-12-31) — Sale Of Investment: 1623737000.00
AOMR income_statement (annual, 2024-12-31) — Selling General And Administration: 2041000.00
AOMR balance_sheet (annual, 2024-12-31) — Share Issued: 23500175.00
AOMR cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2041000.00
AOMR balance_sheet (annual, 2024-12-31) — Stockholders Equity: 238967000.00
AOMR balance_sheet (annual, 2024-12-31) — Tangible Book Value: 238967000.00
AOMR income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
AOMR income_statement (annual, 2024-12-31) — Tax Provision: 3261000.00
AOMR income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.07
AOMR balance_sheet (annual, 2024-12-31) — Total Assets: 2269769000.00
AOMR balance_sheet (annual, 2024-12-31) — Total Capitalization: 2009778000.00
AOMR balance_sheet (annual, 2024-12-31) — Total Debt: 1770811000.00
AOMR balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 238967000.00
AOMR balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2030802000.00
AOMR balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2785000.00
AOMR cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -23761000.00
AOMR income_statement (quarterly, 2025-03-31) — +Total Revenue: 23530000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 304484000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 9823000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 461294000.00
AOMR cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -38000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 478988000.00
AOMR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 23396151.00
AOMR income_statement (quarterly, 2025-03-31) — Basic EPS: 0.88
AOMR cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 42893000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 234000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 38696000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 43470000.00
AOMR cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -7520000.00
AOMR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 278192000.00
AOMR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -75867000.00
AOMR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -201748000.00
AOMR cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 931000.00
AOMR cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -309000.00
AOMR cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 0.00
AOMR cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 97000.00
AOMR cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -309000.00
AOMR cash_flow (quarterly, 2025-03-31) — Change In Payable: 1440000.00
AOMR cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1131000.00
AOMR cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 0.00
AOMR cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -763000.00
AOMR cash_flow (quarterly, 2025-03-31) — Changes In Cash: 577000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Common Stock: 234000.00
AOMR cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -7520000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 251480000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2787000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 947000.00
AOMR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 23644598.00
AOMR income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.87
AOMR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 20531000.00
AOMR cash_flow (quarterly, 2025-03-31) — End Cash Position: 43470000.00
AOMR cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 278192000.00
AOMR cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -201748000.00
AOMR income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -4039000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -4170000.00
AOMR income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 237000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 2785000.00
AOMR income_statement (quarterly, 2025-03-31) — Interest Expense: 22780000.00
AOMR income_statement (quarterly, 2025-03-31) — Interest Income: 32867000.00
AOMR cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 17517000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2215890000.00
AOMR cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -75867000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 499816000.00
AOMR cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 231011000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1964410000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1964410000.00
AOMR cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 231011000.00
AOMR cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -43211000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 20828000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Net Debt: 1925714000.00
AOMR income_statement (quarterly, 2025-03-31) — Net Income: 20531000.00
AOMR income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 20531000.00
AOMR income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 20531000.00
AOMR income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 20531000.00
AOMR income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 20531000.00
AOMR cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 20531000.00
AOMR income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 20531000.00
AOMR income_statement (quarterly, 2025-03-31) — Net Interest Income: 10087000.00
AOMR cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -75873000.00
AOMR cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 187800000.00
AOMR cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 187800000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 251480000.00
AOMR income_statement (quarterly, 2025-03-31) — Normalized Income: 20531000.00
AOMR cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -201748000.00
AOMR cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 3182000.00
AOMR income_statement (quarterly, 2025-03-31) — Operating Revenue: 23530000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 23500175.00
AOMR balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -4170000.00
AOMR cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -210212000.00
AOMR income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 2762000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Payables: 308444000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 311231000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 819000.00
AOMR income_statement (quarterly, 2025-03-31) — Pretax Income: 20531000.00
AOMR cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -278120000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Receivables: 9823000.00
AOMR cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -43211000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -205878000.00
AOMR income_statement (quarterly, 2025-03-31) — Salaries And Wages: 237000.00
AOMR cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 202247000.00
AOMR income_statement (quarterly, 2025-03-31) — Selling General And Administration: 237000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Share Issued: 23500175.00
AOMR cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 237000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 251480000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 251480000.00
AOMR income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AOMR income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
AOMR income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
AOMR balance_sheet (quarterly, 2025-03-31) — Total Assets: 2676535000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2215890000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Total Debt: 1964410000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 251480000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2425055000.00
AOMR balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 2785000.00
AOMR cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -16625000.00
AOMR income_statement (quarterly, 2025-06-30) — +Total Revenue: 5865000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 256486000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 6836000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 463580000.00
AOMR cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -23000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 367181000.00
AOMR income_statement (quarterly, 2025-06-30) — Basic Average Shares: 23524735.00
AOMR income_statement (quarterly, 2025-06-30) — Basic EPS: 0.03
AOMR cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 43470000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Capital Stock: 238000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 40500000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 44367000.00
AOMR cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -7605000.00
AOMR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -89846000.00
AOMR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 70098000.00
AOMR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 20645000.00
AOMR cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 392000.00
AOMR cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 367000.00
AOMR cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -2622000.00
AOMR cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -1502000.00
AOMR cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -4080000.00
AOMR cash_flow (quarterly, 2025-06-30) — Change In Payable: -2726000.00
AOMR cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -2359000.00
AOMR cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -2622000.00
AOMR cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -4954000.00
AOMR cash_flow (quarterly, 2025-06-30) — Changes In Cash: 897000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Common Stock: 238000.00
AOMR cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -7605000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 246389000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 3205000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 4355000.00
AOMR income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 23787823.00
AOMR income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.03
AOMR income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 767000.00
AOMR cash_flow (quarterly, 2025-06-30) — End Cash Position: 44367000.00
AOMR cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -89846000.00
AOMR cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 20645000.00
AOMR income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -9596000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -4661000.00
AOMR income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 296000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 163000.00
AOMR income_statement (quarterly, 2025-06-30) — Interest Expense: 25154000.00
AOMR income_statement (quarterly, 2025-06-30) — Interest Income: 35094000.00
AOMR cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 19936000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2221538000.00
AOMR cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 70098000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 388173000.00
AOMR cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: -189850000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1975149000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1975149000.00
AOMR cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: -189850000.00
AOMR cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -83256000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 20992000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Net Debt: 1934649000.00
AOMR income_statement (quarterly, 2025-06-30) — Net Income: 767000.00
AOMR income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 767000.00
AOMR income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 767000.00
AOMR income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 767000.00
AOMR income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 767000.00
AOMR cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 767000.00
AOMR income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 767000.00
AOMR income_statement (quarterly, 2025-06-30) — Net Interest Income: 9940000.00
AOMR cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 70092000.00
AOMR cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -273106000.00
AOMR cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -273106000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 246389000.00
AOMR income_statement (quarterly, 2025-06-30) — Normalized Income: 767000.00
AOMR cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 20645000.00
AOMR cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 2499000.00
AOMR income_statement (quarterly, 2025-06-30) — Operating Revenue: 5865000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 23765202.00
AOMR balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -4661000.00
AOMR cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 18423000.00
AOMR income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 4802000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Payables: 257328000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 260533000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 2447000.00
AOMR income_statement (quarterly, 2025-06-30) — Pretax Income: 767000.00
AOMR cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -310672000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Receivables: 6836000.00
AOMR cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -83256000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -212768000.00
AOMR income_statement (quarterly, 2025-06-30) — Salaries And Wages: 296000.00
AOMR cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 380764000.00
AOMR income_statement (quarterly, 2025-06-30) — Selling General And Administration: 296000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Share Issued: 23765202.00
AOMR cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 296000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 246389000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 246389000.00
AOMR income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AOMR income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
AOMR income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
AOMR balance_sheet (quarterly, 2025-06-30) — Total Assets: 2554488000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2221538000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Total Debt: 1975149000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 246389000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2308099000.00
AOMR balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 163000.00
AOMR cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 1576000.00
AOMR income_statement (quarterly, 2025-09-30) — +Total Revenue: 14903000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 155992000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 14781000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 474154000.00
AOMR cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 0.00
AOMR balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 239893000.00
AOMR income_statement (quarterly, 2025-09-30) — Basic Average Shares: 23043587.00
AOMR income_statement (quarterly, 2025-09-30) — Basic EPS: 0.49
AOMR cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 44367000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Capital Stock: 249000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 51598000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 53431000.00
AOMR cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -7839000.00
AOMR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 155761000.00
AOMR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 26654000.00
AOMR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -173351000.00
AOMR cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -85000.00
AOMR cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -711000.00
AOMR cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 0.00
AOMR cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -7235000.00
AOMR cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -3170000.00
AOMR cash_flow (quarterly, 2025-09-30) — Change In Payable: 1076000.00
AOMR cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 365000.00
AOMR cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 0.00
AOMR cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -17985000.00
AOMR cash_flow (quarterly, 2025-09-30) — Changes In Cash: 9064000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Common Stock: 249000.00
AOMR cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -7839000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 264165000.00
AOMR cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 10188000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2540000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 1309000.00
AOMR income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 24560881.00
AOMR income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.46
AOMR income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 11410000.00
AOMR cash_flow (quarterly, 2025-09-30) — End Cash Position: 53431000.00
AOMR cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 155761000.00
AOMR cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -173351000.00
AOMR income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -2066000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -996000.00
AOMR income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 398000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 163000.00
AOMR income_statement (quarterly, 2025-09-30) — Interest Expense: 26479000.00
AOMR income_statement (quarterly, 2025-09-30) — Interest Income: 36659000.00
AOMR cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 22651000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2422225000.00
AOMR cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 26654000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 261057000.00
AOMR cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 10188000.00
AOMR cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 483064000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 2158060000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2158060000.00
AOMR cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 483064000.00
AOMR cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -45689000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 21164000.00
AOMR cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 10188000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Net Debt: 2106462000.00
AOMR income_statement (quarterly, 2025-09-30) — Net Income: 11410000.00
AOMR income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 11410000.00
AOMR income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 11410000.00
AOMR income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 11410000.00
AOMR income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 11410000.00
AOMR cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 11410000.00
AOMR income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 11410000.00
AOMR income_statement (quarterly, 2025-09-30) — Net Interest Income: 10180000.00
AOMR cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 26654000.00
AOMR cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 437375000.00
AOMR cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 437375000.00
AOMR cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -269942000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 264165000.00
AOMR income_statement (quarterly, 2025-09-30) — Normalized Income: 11410000.00
AOMR cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -173351000.00
AOMR cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 6557000.00
AOMR income_statement (quarterly, 2025-09-30) — Operating Revenue: 14903000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 24914035.00
AOMR balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -996000.00
AOMR cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -164481000.00
AOMR income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 2788000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Payables: 157995000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 160535000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 2217000.00
AOMR income_statement (quarterly, 2025-09-30) — Pretax Income: 11717000.00
AOMR cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -252815000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Receivables: 14781000.00
AOMR cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -45689000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -209242000.00
AOMR income_statement (quarterly, 2025-09-30) — Salaries And Wages: 398000.00
AOMR cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 279469000.00
AOMR income_statement (quarterly, 2025-09-30) — Selling General And Administration: 398000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Share Issued: 24914035.00
AOMR cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 397000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 264165000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 264165000.00
AOMR income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AOMR income_statement (quarterly, 2025-09-30) — Tax Provision: 307000.00
AOMR income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.03
AOMR balance_sheet (quarterly, 2025-09-30) — Total Assets: 2638110000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2422225000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Total Debt: 2158060000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 264165000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2373945000.00
AOMR balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 163000.00
AOMR cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -11280000.00
AOMR income_statement (annual, 2025-12-31) — +Total Revenue: 60995000.00
AOMR income_statement (quarterly, 2025-12-31) — +Total Revenue: 16698000.00
AOMR balance_sheet (annual, 2025-12-31) — Accounts Payable: 201614000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 201614000.00
AOMR balance_sheet (annual, 2025-12-31) — Accounts Receivable: 10354000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 10354000.00
AOMR balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 474577000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 474577000.00
AOMR balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 284708000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 284708000.00
AOMR income_statement (annual, 2025-12-31) — Basic Average Shares: 23682302.00
AOMR income_statement (quarterly, 2025-12-31) — Basic Average Shares: 24756801.00
AOMR income_statement (annual, 2025-12-31) — Basic EPS: 1.85
AOMR income_statement (quarterly, 2025-12-31) — Basic EPS: 0.46
AOMR cash_flow (annual, 2025-12-31) — Beginning Cash Position: 42893000.00
AOMR cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 53431000.00
AOMR balance_sheet (annual, 2025-12-31) — Capital Stock: 249000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 249000.00
AOMR balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 41619000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 41619000.00
AOMR balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 45285000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 45285000.00
AOMR cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -30937000.00
AOMR cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -7973000.00
AOMR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 395683000.00
AOMR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 51576000.00
AOMR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 13663000.00
AOMR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -7222000.00
AOMR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -406954000.00
AOMR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -52500000.00
AOMR cash_flow (annual, 2025-12-31) — Change In Account Payable: 2489000.00
AOMR cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1251000.00
AOMR cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -523000.00
AOMR cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 130000.00
AOMR cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -2561000.00
AOMR cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 61000.00
AOMR cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -8160000.00
AOMR cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 480000.00
AOMR cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -4985000.00
AOMR cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 2574000.00
AOMR cash_flow (annual, 2025-12-31) — Change In Payable: -75000.00
AOMR cash_flow (quarterly, 2025-12-31) — Change In Payable: 135000.00
AOMR cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -598000.00
AOMR cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 265000.00
AOMR cash_flow (annual, 2025-12-31) — Change In Receivables: -2213000.00
AOMR cash_flow (annual, 2025-12-31) — Change In Tax Payable: -2561000.00
AOMR cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 61000.00
AOMR cash_flow (annual, 2025-12-31) — Change In Working Capital: -15956000.00
AOMR cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 7746000.00
AOMR cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -2213000.00
AOMR cash_flow (annual, 2025-12-31) — Changes In Cash: 2392000.00
AOMR cash_flow (quarterly, 2025-12-31) — Changes In Cash: -8146000.00
AOMR balance_sheet (annual, 2025-12-31) — Common Stock: 249000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Common Stock: 249000.00
AOMR cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -30937000.00
AOMR cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -7973000.00
AOMR balance_sheet (annual, 2025-12-31) — Common Stock Equity: 267523000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 267523000.00
AOMR cash_flow (annual, 2025-12-31) — Common Stock Issuance: 12181000.00
AOMR cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: -1000.00
AOMR cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
AOMR cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
AOMR balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2804000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2804000.00
AOMR balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 32000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 32000.00
AOMR income_statement (annual, 2025-12-31) — Diluted Average Shares: 24314625.00
AOMR income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 25204204.00
AOMR income_statement (annual, 2025-12-31) — Diluted EPS: 1.80
AOMR income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.45
AOMR income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 43852000.00
AOMR income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 11144000.00
AOMR cash_flow (annual, 2025-12-31) — End Cash Position: 45285000.00
AOMR cash_flow (quarterly, 2025-12-31) — End Cash Position: 45285000.00
AOMR cash_flow (annual, 2025-12-31) — Financing Cash Flow: 395683000.00
AOMR cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 51576000.00
AOMR cash_flow (annual, 2025-12-31) — Free Cash Flow: -406954000.00
AOMR cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -52500000.00
AOMR income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -7818000.00
AOMR income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 53000.00
AOMR balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1314000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1314000.00
AOMR income_statement (annual, 2025-12-31) — General And Administrative Expense: 1354000.00
AOMR income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 424000.00
AOMR cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 3275000.00
AOMR balance_sheet (annual, 2025-12-31) — Income Tax Payable: 0.00
AOMR balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 0.00
AOMR income_statement (annual, 2025-12-31) — Interest Expense: 102555000.00
AOMR income_statement (quarterly, 2025-12-31) — Interest Expense: 28141000.00
AOMR income_statement (annual, 2025-12-31) — Interest Income: 143655000.00
AOMR income_statement (quarterly, 2025-12-31) — Interest Income: 39035000.00
AOMR cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 94895000.00
AOMR cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 34791000.00
AOMR balance_sheet (annual, 2025-12-31) — Invested Capital: 2490624000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2490624000.00
AOMR cash_flow (annual, 2025-12-31) — Investing Cash Flow: 13663000.00
AOMR cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -7222000.00
AOMR balance_sheet (annual, 2025-12-31) — Investments And Advances: 310182000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 310182000.00
AOMR cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 12181000.00
AOMR cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: -1000.00
AOMR cash_flow (annual, 2025-12-31) — Issuance Of Debt: 130459000.00
AOMR cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -393766000.00
AOMR balance_sheet (annual, 2025-12-31) — Long Term Debt: 2223101000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 2223101000.00
AOMR balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2223101000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2223101000.00
AOMR cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 130459000.00
AOMR cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -393766000.00
AOMR cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -249373000.00
AOMR cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -77217000.00
AOMR balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 25474000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 25474000.00
AOMR cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 12181000.00
AOMR cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1000.00
AOMR balance_sheet (annual, 2025-12-31) — Net Debt: 2181482000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Net Debt: 2181482000.00
AOMR income_statement (annual, 2025-12-31) — Net Income: 44024000.00
AOMR income_statement (quarterly, 2025-12-31) — Net Income: 11316000.00
AOMR income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 43852000.00
AOMR income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 11144000.00
AOMR income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 44024000.00
AOMR income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 11316000.00
AOMR income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 44024000.00
AOMR income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 11316000.00
AOMR income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 44024000.00
AOMR income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 11316000.00
AOMR cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 44024000.00
AOMR cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 11316000.00
AOMR income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 44024000.00
AOMR income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 11316000.00
AOMR income_statement (annual, 2025-12-31) — Net Interest Income: 41100000.00
AOMR income_statement (quarterly, 2025-12-31) — Net Interest Income: 10894000.00
AOMR cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 13651000.00
AOMR cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -7222000.00
AOMR cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -118914000.00
AOMR cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -470983000.00
AOMR cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -118914000.00
AOMR cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -470983000.00
AOMR cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 529867000.00
AOMR cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 530533000.00
AOMR balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 267523000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 267523000.00
AOMR income_statement (annual, 2025-12-31) — Normalized Income: 44024000.00
AOMR income_statement (quarterly, 2025-12-31) — Normalized Income: 11316000.00
AOMR cash_flow (annual, 2025-12-31) — Operating Cash Flow: -406954000.00
AOMR cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -52500000.00
AOMR cash_flow (annual, 2025-12-31) — Operating Gains Losses: 10863000.00
AOMR cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1375000.00
AOMR income_statement (annual, 2025-12-31) — Operating Revenue: 60995000.00
AOMR income_statement (quarterly, 2025-12-31) — Operating Revenue: 16698000.00
AOMR balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 24914647.00
AOMR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 24914647.00
AOMR balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -1314000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -1314000.00
AOMR cash_flow (annual, 2025-12-31) — Other Non Cash Items: -424753000.00
AOMR cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -68483000.00
AOMR income_statement (annual, 2025-12-31) — Other Non Interest Expense: 15086000.00
AOMR income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 4734000.00
AOMR balance_sheet (annual, 2025-12-31) — Payables: 202277000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Payables: 202277000.00
AOMR balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 205081000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 205081000.00
AOMR income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 172000.00
AOMR balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1553000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1553000.00
AOMR income_statement (annual, 2025-12-31) — Pretax Income: 44555000.00
AOMR income_statement (quarterly, 2025-12-31) — Pretax Income: 11540000.00
AOMR cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1002583000.00
AOMR cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -160976000.00
AOMR balance_sheet (annual, 2025-12-31) — Receivables: 10354000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Receivables: 10354000.00
AOMR cash_flow (annual, 2025-12-31) — Repayment Of Debt: -249373000.00
AOMR cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -77217000.00
AOMR cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
AOMR cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
AOMR balance_sheet (annual, 2025-12-31) — Retained Earnings: -205989000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -205989000.00
AOMR income_statement (annual, 2025-12-31) — Salaries And Wages: 1354000.00
AOMR income_statement (quarterly, 2025-12-31) — Salaries And Wages: 424000.00
AOMR cash_flow (annual, 2025-12-31) — Sale Of Investment: 1016234000.00
AOMR cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 153754000.00
AOMR income_statement (annual, 2025-12-31) — Selling General And Administration: 1354000.00
AOMR income_statement (quarterly, 2025-12-31) — Selling General And Administration: 424000.00
AOMR balance_sheet (annual, 2025-12-31) — Share Issued: 24914647.00
AOMR balance_sheet (quarterly, 2025-12-31) — Share Issued: 24914647.00
AOMR cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1354000.00
AOMR cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 424000.00
AOMR balance_sheet (annual, 2025-12-31) — Stockholders Equity: 267523000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 267523000.00
AOMR balance_sheet (annual, 2025-12-31) — Tangible Book Value: 267523000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 267523000.00
AOMR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AOMR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AOMR income_statement (annual, 2025-12-31) — Tax Provision: 531000.00
AOMR income_statement (quarterly, 2025-12-31) — Tax Provision: 224000.00
AOMR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.04
AOMR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.02
AOMR balance_sheet (annual, 2025-12-31) — Total Assets: 2749778000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Total Assets: 2749778000.00
AOMR balance_sheet (annual, 2025-12-31) — Total Capitalization: 2490624000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2490624000.00
AOMR balance_sheet (annual, 2025-12-31) — Total Debt: 2223101000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Total Debt: 2223101000.00
AOMR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 267523000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 267523000.00
AOMR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2482255000.00
AOMR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2482255000.00
AOMR balance_sheet (annual, 2025-12-31) — Total Tax Payable: 0.00
AOMR balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 0.00
AOMR cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -30758000.00
AOMR cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -4429000.00
AOMR income_statement (quarterly, 2026-03-31) — +Total Revenue: -2203000.00
AOMR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 131249000.00
AOMR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 11269000.00
AOMR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 475000000.00
AOMR cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: 0.00
AOMR balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 217599000.00